Neuronal Ceroid Lipofuscinosis: Impact of Recent Genetic Advances and Expansion of the Clinicopathologic Spectrum
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Neuronal ceroid lipofuscinosis (NCL), first clinically described in 1826 and pathologically defined in the 1960s, refers to a group of disorders mostly diagnosed in the childhood years that involve the accumulation of lysosomal storage material with characteristic ultrastructure and prominent neurodegenerative features including vision loss, seizures, motor and cognitive function deterioration, and often times, psychiatric disturbances. All NCL disorders evidence early morbidity and treatment options are limited to symptomatic and palliative care. While distinct genetic forms of NCL have long been recognized, recent genetic advances are considerably widening the NCL genotypic and phenotypic spectrum, highlighting significant overlap with other neurodegenerative diseases. This review will discuss these recent advances and the expanded potential for increased awareness and new research that will ultimately lead to effective treatments for NCL and related disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ramirez, A., Heimbach, A., Gründemann, J., Stiller, B., Hampshire, D., Cid, L. P., Goebel, I., Mubaidin, A. F., Wriekat, A.-L., Roeper, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1884 · Cited by 1,208
Biogenesis and Function of Multivesicular Bodies
Piper, R. C., & Katzmann, D. J. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123319 · Cited by 771 · cited 1×
“CUL3 has also been recently recognized as playing an important role in late endosomal maturation [56], and it is known that ubiquitin modification is an important mechanism regulating protein trafficking and signaling pathways within the endosomal system [57].”
BackgroundStrikingly Different Clinicopathological Phenotypes Determined by Progranulin-Mutation Dosage
Smith, K. R., Damiano, J., Franceschetti, S., Carpenter, S., Canafoglia, L., Morbin, M., Rossi, G., Pareyson, D., Mole, S. E., Staropoli, J. F., et al. (2012) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2012.04.021 · Cited by 489
Self-citationEarly‐onset familial parkinsonism due to POLG mutations
Davidzon, G., Greene, P., Mancuso, M., Klos, K. J., Ahlskog, J. E., Hirano, M., & DiMauro, S. (2006) · Annals of Neurology · doi:10.1002/ana.20831 · Cited by 239 · cited 1×
“Mutations in DNA polymerase gamma 1 (POLG1), which encodes the catalytic subunit of the mitochondrial DNA polymerase, have been linked to early-onset forms of parkinsonism [87, 88].”
BackgroundYin, F., Dumont, M., Banerjee, R., Ma, Y., Li, H., Lin, M. T., Beal, M. F., Nathan, C., Thomas, B., & Ding, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-161471 · Cited by 180 · cited 1×
“Other studies describe some behavioral abnormalities in homozygous mice, including social interaction deficits and enhanced aggression, that may be seen in clinical FTLD [65–67], but interestingly, heterozygous mice, which might be expected to model human FTLD-TDP given the suspected haploinsufficiency mechanism, have…”
BackgroundATP13A2 regulates mitochondrial bioenergetics through macroautophagy
Gusdon, A. M., Zhu, J., Van Houten, B., & Chu, C. T. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.015 · Cited by 167 · cited 1×
“Kufor-Rakeb associated mutations in ATP13A2 have also been linked to defective mitochondrial quality control mediated by mitophagy [90], suggesting that forms of NCL caused by ATP13A2mutations may reveal similar pathology.”
BackgroundProgranulin expression in the developing and adult murine brain
Petkau, T. L., Neal, S. J., Orban, P. C., MacDonald, J. L., Hill, A. M., Lu, G., Feldman, H. H., Mackenzie, I. R. A., & Leavitt, B. R. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22430 · Cited by 152 · cited 1×
“The functions of progranulin and the cleaved granulins are unknown, but their expression is particularly high in neurons and activated immune cells [37–39], suggesting they are likely to play an important role in neuronal function and inflammation [35, 36].”
BackgroundCathepsin F mutations cause Type B Kufs disease, an adult-onset neuronal ceroid lipofuscinosis
Smith, K. R., Dahl, H.-H. M., Canafoglia, L., Andermann, E., Damiano, J., Morbin, M., Bruni, A. C., Giaccone, G., Cossette, P., Saftig, P., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds558 · Cited by 130 · cited 2×
“Further investigation of a Ctsf knock-out mouse model strongly supported these findings, as these mice likewise displayed classical NCL-like storage material and phenotypes [51].”
BackgroundResultSelf-citationThe Role of Ceroid Lipofuscinosis Neuronal Protein 5 (CLN5) in Endosomal Sorting
Mamo, A., Jules, F., Dumaresq-Doiron, K., Costantino, S., & Lefrancois, S. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06726-11 · Cited by 79
Cited by
Lui, H., Zhang, J., Makinson, S. R., Cahill, M. K., Kelley, K. W., Huang, H.-Y., Shang, Y., Oldham, M. C., Martens, L. H., Gao, F., et al. (2016) · Cell · doi:10.1016/j.cell.2016.04.001 · Cited by 729
“The connection between FTLD caused by GRN mutations and NCL is intriguing because neuroinflammation is a prominent and consistent feature in animal models of NCL and lysosomal storage diseases (Castaneda et al., 2008; Cotman et al., 2013).”
The lysosomal function of progranulin, a guardian against neurodegeneration
Paushter, D. H., Du, H., Feng, T., & Hu, F. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1861-8 · Cited by 230
“NCLs were previously classified by age of onset, but, with progressing molecular technologies, are now classified by genetic cause, of which 13 specific genes (CLN1-13), including GRN (CLN11), have been identified [26, 86].”
Radke, J., Stenzel, W., & Goebel, H. H. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.007 · Cited by 122
Zhou, X., Sullivan, P. M., Sun, L., & Hu, F. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14110 · Cited by 44
Metadata
- Authors
- Cotman, S. L., Karaa, A., Staropoli, J. F., & Sims, K. B.
- Venue
- Current Neurology and Neuroscience Reports
- Published
- 2013-06-18
- Volume
- 13
- Issue
- 8
- Pages
- 366-366
- ISSN
- 1528-4042 (ISSN-L)
- 1534-6293
- OpenAlex
- W2081925752
- Cited by
- 70
- References
- 9
- FWCI
- 5.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuronal Ceroid Lipofuscinosis: Impact of Recent Genetic Advances and Expansion of the Clinicopathologic Spectrum. https://app.cochat.ai/papers/10.1007/s11910-013-0366-z
- The paper
- Cotman, S. L., Karaa, A., Staropoli, J. F., & Sims, K. B. (2013). Neuronal Ceroid Lipofuscinosis: Impact of Recent Genetic Advances and Expansion of the Clinicopathologic Spectrum. Current Neurology and Neuroscience Reports. https://doi.org/10.1007/s11910-013-0366-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.